Search filters

List of works by María Teresa Gómez Casares

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.

scientific article

An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.

scientific article

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.

scientific article published on 12 May 2016

Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.

scientific article

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.

scientific article

CALR mutation characterization in myeloproliferative neoplasms

scientific article published on July 2016

Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.

scientific article published on 17 April 2017

Colony-stimulating factor-3 receptor, watch out for polymorphisms.

scientific article

Comparative study of BCR-ABL1 quantification: Xpert assay, a feasible solution to standardization concerns.

scientific article published on 25 April 2012

Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase

scientific article

Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes

scientific article

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

scientific article published on 22 February 2018

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera.

scientific article published on 21 December 2015

High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle

scientific article

High resolution melting analysis: a rapid and accurate method to detect CALR mutations.

scientific article

Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents.

scientific article

MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27KIP1

scientific article published on June 18, 2012

MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib.

scientific article published on April 2011

MYC oncogene in myeloid neoplasias.

scientific article published on 22 August 2012

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

scientific article published on 13 July 2017

PU.1 expression is restored upon treatment of chronic myeloid leukemia patients.

scientific article published on 16 July 2008

Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis.

scientific article published on 22 September 2017

Positive Impact of Eculizumab Therapy on Surgery for Budd-Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Long-Term History of Thrombosis.

scientific article

Prognostic risk models for transplant decision-making in myelofibrosis.

scientific article

Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.

scientific article published on 18 June 2012

Renin expression in acute leukaemia

scientific article published on March 1, 2013

Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea

scientific article published on 29 September 2016

SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.

scientific article

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

scientific article

Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology

scientific article published on 3 April 2017

[Chronic myeloid leukemia and resistance to tyrosine kinase inhibitors: ABL mutations, much ado about nothing?]

scientific article published on 22 February 2013